Navigation Links
Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
Date:12/16/2008

AURORA, Ontario, Dec. 16 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: HBP) reports that at its Annual General Meeting held today, shareholders overwhelmingly approved all of management's proposals.

Annual General Meeting Results

All seven Board members were re-elected as directors, with the Board continuing to be constituted of:

    Donald H. Segal        Chairman of the Board and Chief Executive Officer
    Kenneth A. Cawkell     Director and Corporate Secretary
    John Docherty          Director and President
    Thomas Hodgson         Director
    Jack Kay               Director
    Gordon M. Lickrish     Director
    Slawomir Majewski      Director

KPMG LLP was re-appointed as the Company's auditor.

The shareholders also approved the Company's 2008 new Stock Option Plan. Details regarding the new plan are contained in the Company's Information Circular dated Oct. 28, 2008, filed on SEDAR at www.sedar.com.

Research & Development Update

The Company is continuing its efforts toward milestone investigational new drug application (IND) filings in the United States for L-DOS47 and Topical Interferon Alpha-2b, in its cervical dysplasia indication, by the end of its 2009 fiscal year ending July 31, 2009.

L-DOS47

Helix intends to conduct a pre-IND meeting with the FDA to confirm its North American Phase I program plans for L-DOS47. The Company expects the pre-IND meeting to occur in the beginning of the 2009 calendar year. Pending the positive outcome of the pre-IND meeting and timely success of the ongoing and remaining pre-clinical and manufacturing preparatory initiatives, the Phase I IND filing for this program is anticipated to occur sometime before the
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CSL Behrings Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance
2. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
3. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
4. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
5. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
7. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
8. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
9. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
10. CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
11. Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... Ticket Down is a dependable source ... popular ticket exchange is offering their customer appreciation promo code ... of tours is beginning to fill up. Many of the ... hit the road, including 21-year-old pop superstar, Ariana Grande. Grande, ... which will take her to 25 cities across the United ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 As ... grow in federal court, Bernstein Liebhard LLP notes ... Administration (FDA) have voted overwhelmingly to recommend that ... men be subjected to further study in order ... report published on September 18th by Bloomberg.com, the ...
(Date:9/20/2014)... 19, 2014 (HealthDay News) -- The avian flu that ... could be spread through respiratory drops and therefore poses ... study. Although no human illnesses have been linked ... Children,s Research hospital have discovered natural mutations to the ... travel through the air in droplets. Current seasonal ...
(Date:9/20/2014)... 2014 Ticket Down is a ... for her 2015 “Honeymoon Tour.” This well-known ticket exchange ... savings. , In early 2015, fans will have a chance ... across North America. Twenty-one-year-old Ariana Grande will hit the road ... her to 25 cities across the United States and Canada. ...
(Date:9/20/2014)... September 20, 2014 iFitDress.com, the popular ... for women, has recently unveiled its new collection of ... sale for special offer on these new outfits; it ... season. All customers can now buy cheap cocktail ... company’s sales representative says, “We have extensive experience in ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2
... , , GREENDALE, Wis., Dec. ... in the country, introduces The Comfort Food Diet Cookbook, ... fat and calories. The Comfort Food Diet Cookbook , on ... and living that helps readers shed pounds without feeling deprived. Enjoy ...
... Certain genes switch their nuclear position in tumor cells, offering ... the National Cancer Institute. The study by Meaburn et al. ... and in the December 14, 2009 print issue of the ... preferentially localize to specific points within the nucleus. The reasons ...
... December 2009 Elsevier, the world-leading publisher ... and services, proudly announces the early success ... Pharmacology and Therapeutics: Principles to Practice ( ... designed to better meet the needs of ...
... ... important steps healthcare organizations should take to comply with requirements set forth in the ... ... -- Data security experts at Kroll Fraud Solutions will host a webinar ...
... children need to discuss sexual matters sooner, researchers say ... comes to talking about sex, parents are a few ... conversation occurs after, and not before, kids start experimenting ... the January issue of Pediatrics . , This ...
... , ATLANTA, Dec. 7 ... the intravenous formulation of the antiepileptic drug (AED) Vimpat® for ... therapy is temporarily not feasible. These data, which were ... American Epilepsy Society in Boston, further clarify the role of ...
Cached Medicine News:Health News:The Country's Largest Cooking Magazine Announces The Comfort Food Diet Cookbook 2Health News:The Country's Largest Cooking Magazine Announces The Comfort Food Diet Cookbook 3Health News:Elsevier introduces innovative new pharmacology text 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 3Health News:Sex Talk Taking Place After the Fact 2Health News:Sex Talk Taking Place After the Fact 3Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 2Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 3Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 4Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 5
(Date:9/19/2014)... Harwood Feffer LLP ( www.hfesq.com ) is ... PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: ... its fiduciary duties to shareholders or violated the federal ... Company disclosed: "On September 11, 2014, [PDL] was orally ... Young LLP ("EY"), that it was resigning effective September ...
(Date:9/19/2014)... WASHINGTON , Sept. 19, 2014 /PRNewswire-USNewswire/ ... often used to inflate sales of brand drugs ... Part D,  according to a new report ... Services Office of the Inspector General (OIG). Federal anti-kickback ... sales of goods that are subsidized by the ...
(Date:9/19/2014)... Today, iHealth Lab Inc. announced it has secured ... its first institutional round of funding. The strategic investment ... accelerate growth and innovation, and invest in additional sales ... Ventures will join iHealth,s board of directors, bringing added ... "We are very pleased to have Xiaomi ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2
... Advanced Health Media (AHM), the leading supplier ... for the pharmaceutical industry, has named Paul O,Toole ... Delivery, effective immediately. Paul brings over 20 years ... organizations, including software and product development, implementation, professional ...
... Cardica, Inc. (Nasdaq: CRDC ) today ... be featured in a clinical presentation to cardiothoracic ... Institute-International Society for Minimally Invasive Cardiothoracic Surgery (ECHI-ISMICS) ... "Robotic Coronary Revascularization: Connectors and Pearls," will be ...
Cached Medicine Technology:Advanced Health Media, Inc. Announces New SVP Product Delivery 2Cardica's Cardiac Anastomosis Device Featured in Clinical Presentation on Robotic Cardiac Bypass Procedures 2Cardica's Cardiac Anastomosis Device Featured in Clinical Presentation on Robotic Cardiac Bypass Procedures 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: